|
Can't see this email properly? Click here to view an online version | ||||||||||||||
Dear Jon,
It is our great pleasure to present our first issue of The Lancet Microbe, a new gold open access journal published by The Lancet. We are committed to publishing content relevant to clinical microbiologists worldwide, with a focus on studies that advance clinical practice, challenge the status quo, and advocate change in health policy.
It will come as no surprise that this is a challenging time to launch a medical journal, particularly one focusing on research into pathogens. However, current events have also made it clear that a journal such as ours has arrived just in time to help the microbial research community as it works tirelessly to uncover the inner workings of SARS-CoV-2. Our first issue carries a variety of information on this new virus, from its stability in the environment to its behaviour in numerous cell lines. Furthermore, this issue includes discussion of the need for renewed vigilance around viruses that pose a zoonotic risk, a discussion of ultraviolet light as a sanitising agent, and a call for thorough scrutiny of coinfections in patients with COVID-19.
We hope that you find our content to be both interesting and useful to your work. Find out more about us with our additional resources included below.
Onisillos Sekkides
Editor-in-Chief
Elena C. Dalla Vecchia
Senior Editor
P.S. To assist health workers and researchers working under challenging conditions to bring the COVID-19 outbreak to a close, The Lancet created a Coronavirus Resource Centre. This resource brings together relevant new content from across the Lancet journals as it publishes. All our COVID-19 content is free to access.
Explore our additional resources
|
Đăng nhận xét